End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma

Gut. 2022 Mar;71(3):454-456. doi: 10.1136/gutjnl-2021-324288. Epub 2021 Mar 30.
No abstract available

Keywords: antiviral therapy; hepatitis C; hepatocellular carcinoma; meta-analysis.

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / pathology
  • Hepacivirus
  • Hepatitis C, Chronic* / drug therapy
  • Humans
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / pathology
  • Neoplasm Recurrence, Local / drug therapy

Substances

  • Antiviral Agents